These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11697062)

  • 1. Comparative receptor surface analysis (CoRSA) model for calcium channel antagonists.
    Ivanciuc O; Ivanciuc T; Cabrol-Bass D
    SAR QSAR Environ Res; 2001; 12(1-2):93-111. PubMed ID: 11697062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines.
    Yao X; Liu H; Zhang R; Liu M; Hu Z; Panaye A; Doucet JP; Fan B
    Mol Pharm; 2005; 2(5):348-56. PubMed ID: 16196487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative receptor surface analysis of agonists for tyramine receptor which inhibit sex-pheromone production in Plodia interpunctella.
    Hirashima A; Eiraku T; Kuwano E; Eto M
    Comb Chem High Throughput Screen; 2004 Mar; 7(2):83-91. PubMed ID: 15032656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Venkatarangan P; Hopfinger AJ
    J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS.
    Mohajeri A; Hemmateenejad B; Mehdipour A; Miri R
    J Mol Graph Model; 2008 Apr; 26(7):1057-65. PubMed ID: 17959402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
    Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
    Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
    Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular surface-based 3D-QSAR method using Kohonen neural network and 3-way PLS.
    Hasegawa K; Matsuoka S; Arakawa M; Funatsu K
    Comput Chem; 2002 Nov; 26(6):583-9. PubMed ID: 12385475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3D-QSAR of angiotensin II (AT1) receptor antagonists based on receptor surface analysis.
    Datar PA; Desai PV; Coutinho EC
    J Chem Inf Comput Sci; 2004; 44(1):210-20. PubMed ID: 14741030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
    Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
    SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures.
    Hemmateenejad B; Safarpour MA; Miri R; Taghavi F
    J Comput Chem; 2004 Sep; 25(12):1495-503. PubMed ID: 15224393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.
    Ekins S; Bravi G; Binkley S; Gillespie JS; Ring BJ; Wikel JH; Wrighton SA
    Pharmacogenetics; 1999 Aug; 9(4):477-89. PubMed ID: 10780267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional holograph vector of atomic interaction field (3D-HoVAIF): a novel rotation-translation invariant 3D structure descriptor and its applications to peptides.
    Tian F; Zhou P; Lv F; Song R; Li Z
    J Pept Sci; 2007 Aug; 13(8):549-66. PubMed ID: 17654623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
    Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ
    J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
    Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
    J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
    Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
    J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.